Literature DB >> 21844550

Screening for bladder cancer: U.S. Preventive Services Task Force recommendation statement.

Virginia A Moyer1.   

Abstract

DESCRIPTION: Update of the 2004 U.S. Preventive Services Task Force (USPSTF) recommendation statement on screening for bladder cancer.
METHODS: The USPSTF performed a targeted literature search for new evidence on the benefits and harms of screening, the accuracy of primary care-feasible screening tests, and the benefits and harms of treatment. RECOMMENDATION: The USPSTF concludes that the current evidence is insufficient to assess the balance of benefits and harms of screening for bladder cancer in asymptomatic adults (I statement).

Entities:  

Mesh:

Year:  2011        PMID: 21844550     DOI: 10.7326/0003-4819-155-4-201108160-00008

Source DB:  PubMed          Journal:  Ann Intern Med        ISSN: 0003-4819            Impact factor:   25.391


  11 in total

1.  Association between longer therapy with thiazolidinediones and risk of bladder cancer: a cohort study.

Authors:  Ronac Mamtani; Kevin Haynes; Warren B Bilker; David J Vaughn; Brian L Strom; Karen Glanz; James D Lewis
Journal:  J Natl Cancer Inst       Date:  2012-08-09       Impact factor: 13.506

2.  Establishment of a bladder cancer cell line expressing both mesenchymal and epithelial lineage-associated markers.

Authors:  Mohammadrasul Zareinejad; Zahra Faghih; Ali Ariafar; Akbar Safaei; Abbas Ghaderi
Journal:  Hum Cell       Date:  2020-11-09       Impact factor: 4.174

3.  CKD and risk of renal cell carcinoma: a causal association?

Authors:  Jonathan N Hofmann; Mark P Purdue
Journal:  J Am Soc Nephrol       Date:  2014-05-29       Impact factor: 10.121

4.  Role of serum and urine transforming growth factor beta 1, matrix metallopeptidase 9, tissue inhibitor of metalloproteinase 2, and nerve growth factor beta levels and serum neutrophil-to-lymphocyte ratio in predicting recurrence and progression risks in patients with primary non-muscle invasive bladder cancer.

Authors:  Özgür Efiloğlu; Banu İşbilen Başok; Turgay Turan; Tuncay Toprak; Bülent Erol; Turhan Çaşkurlu; Asıf Yıldırım
Journal:  Turk J Urol       Date:  2020-02-07

5.  A global, regional, and national survey on burden and Quality of Care Index (QCI) of bladder cancer: The global burden of disease study 1990-2019.

Authors:  Amirali Karimi; Parnian Shobeiri; Sina Azadnajafabad; Masoud Masinaei; Negar Rezaei; Ali Ghanbari; Nazila Rezaei; Mahtab Rouhifard; Sarvenaz Shahin; Mohammad-Mahdi Rashidi; Mohammad Keykhaei; Ameneh Kazemi; Erfan Amini; Bagher Larijani; Farshad Farzadfar
Journal:  PLoS One       Date:  2022-10-20       Impact factor: 3.752

6.  A noninvasive multianalyte urine-based diagnostic assay for urothelial cancer of the bladder in the evaluation of hematuria.

Authors:  R Jeffrey Karnes; Cecilia A Fernandez; Anthony P Shuber
Journal:  Mayo Clin Proc       Date:  2012-08-09       Impact factor: 7.616

7.  Mortality and cancer incidence in a pooled cohort of US firefighters from San Francisco, Chicago and Philadelphia (1950-2009).

Authors:  Robert D Daniels; Travis L Kubale; James H Yiin; Matthew M Dahm; Thomas R Hales; Dalsu Baris; Shelia H Zahm; James J Beaumont; Kathleen M Waters; Lynne E Pinkerton
Journal:  Occup Environ Med       Date:  2013-10-14       Impact factor: 4.402

8.  γ-H2AX level in peripheral blood lymphocytes as a risk predictor for bladder cancer.

Authors:  Mario I Fernández; Yilei Gong; Yuanqing Ye; Jie Lin; David W Chang; Ashish M Kamat; Xifeng Wu
Journal:  Carcinogenesis       Date:  2013-08-14       Impact factor: 4.944

9.  Cancer Screening in Refugees and Immigrants: A Global Perspective.

Authors:  Patricia F Walker; Ann Settgast; Malini B DeSilva
Journal:  Am J Trop Med Hyg       Date:  2022-05-09       Impact factor: 3.707

10.  Risk of extracolonic cancers for people with biallelic and monoallelic mutations in MUTYH.

Authors:  Aung Ko Win; Jeanette C Reece; James G Dowty; Daniel D Buchanan; Mark Clendenning; Christophe Rosty; Melissa C Southey; Joanne P Young; Sean P Cleary; Hyeja Kim; Michelle Cotterchio; Finlay A Macrae; Katherine M Tucker; John A Baron; Terrilea Burnett; Loïc Le Marchand; Graham Casey; Robert W Haile; Polly A Newcomb; Stephen N Thibodeau; John L Hopper; Steven Gallinger; Ingrid M Winship; Noralane M Lindor; Mark A Jenkins
Journal:  Int J Cancer       Date:  2016-06-02       Impact factor: 7.316

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.